The Nitinol wire braided construction allows the WallFlex Esophageal Stent
to provide luminal patency in the presence of strictures or tumors.
The WallFlex(R) Partially Covered Esophageal Stent
was cleared by the FDA and received CE Mark in 2008.
The Evolution Fully Covered Stent is an esophageal stent
with silicone internal and external of the stent that resists tumor ingrowth and makes swallowing more comfortable for the patient.
self-expanding esophageal stent
, nitinol mesh and partially cover 22cm 10cms.
Food and Drug Administration (FDA) for use of the Evolution[R] Controlled Release Esophageal Stent
Food and Drug Administration (FDA) to market its BONASTENT[R] Fully Covered Esophageal Stent
for the treatment of malignant esophageal obstructions, and its BONASTENT Uncovered Biliary Stent for the treatment of malignant biliary obstructions.
The role of esophageal stents
in the management of esophageal anastomotic leaks and benign esophageal perforations.
Major updates include advanced techniques such as the endoscopic pancreato-cholangiography, esophageal stenting with removable and biodegradable esophageal stents
, and pancreatic cysto-gastrostomy, among others.
The Evolution colonic stent adds to the existing line of Evolution stents, which includes fully covered, partially covered, and uncovered esophageal stents
, as well as the duodenal stent which received FDA approval in March of 2011.